Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide
Clinical trial NCT02379390 · TERMINATED
Trial details
- NCT number
- NCT02379390
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-17
- Primary completion
- 2018-05-10
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.